PetMed Express reports Q3 EPS (3c) vs. (10c) last year

Reports Q3 revenue $52.98M vs. $65.32M last year. “In just nine months, we have made significant strides in our transformation journey, and I am pleased to report that we have delivered meaningful progress across our strategic priorities. Our focused execution is already yielding results, validating our direction and setting the foundation for long-term success. For the third quarter, we achieved $2 million in Adjusted EBITDA, a $1.1 million improvement year-over-year, while successfully reducing G&A expenses by $2.6 million compared to last year. As we continue to build a stronger, more efficient organization, our commitment remains unwavering-to drive differentiation, sustainable growth, and increased shareholder value through operational excellence and financial discipline,” said Sandra Campos, CEO and president.